Richard Scott Struthers, President & CEO: Crinetics Pharmaceuticals CRNX Sell · Filed 03/18

Trade details

Type: Insider sale
Amount: $331,809.45
Shares · price: 8,785 sh · $37.77 a share
Held after: 404,778 sh
Stock: Crinetics Pharmaceuticals CRNX
Person: Richard Scott StruthersPresident & CEO
Trade date: 26/03/16
Filed: 26/03/18
Days to filing: 2 days

Sold 2.1% of holdings

Share of holding sold: 2.1%

Crinetics Pharmaceuticals trades, last 26 weeks

What else happened in Crinetics Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 02/14~04/15

Richard Scott Struthers's recent trades

Richard Scott StruthersPresident & CEO
Sell10b5-1 planCrinetics Pharmaceuticals
Sell10b5-1 plan
Crinetics Pharmaceuticals
CRNX
$489.7K
13,196 sh
$489.7K
Filed 03/18
Traded 03/16
Richard Scott StruthersPresident & CEO
Sell10b5-1 planCrinetics Pharmaceuticals
Sell10b5-1 plan
Crinetics Pharmaceuticals
CRNX
$180K
4,000 sh
$180K
Filed 25/09/30
Traded 25/09/26
Richard Scott StruthersPresident & CEO
Sell10b5-1 planCrinetics Pharmaceuticals
Sell10b5-1 plan
Crinetics Pharmaceuticals
CRNX
$562.5K
16,463 sh
$562.5K
Filed 25/03/21
Traded 25/03/19
Richard Scott StruthersPresident & CEO
Sell10b5-1 planCrinetics Pharmaceuticals
Sell10b5-1 plan
Crinetics Pharmaceuticals
CRNX
$30.5K
875 sh
$30.5K
Filed 25/03/21
Traded 25/03/19
Richard Scott StruthersPresident & CEO
Sell10b5-1 planCrinetics Pharmaceuticals
Sell10b5-1 plan
Crinetics Pharmaceuticals
CRNX
$575.7K
10,000 sh
$575.7K
Filed 24/12/04
Traded 24/12/02

Richard Scott Struthers, CEO — sold $331.8K of Crinetics Pharmaceuticals CRNX · 2.1% of holdings · 10b5-1 plan | Whalegun